Haven't had much time lately? Here's what you may have missed in the last few weeks.
Sign-up to receive the OncologyPRO alert
every 2 weeks.
Find all the latest ESMO Guidelines
, new Pan Asian Guidelines
and
discover the ESMO Guidelines Slide Sets
!
For full access to all OncologyPRO content: daily medwireNews, ESMO books, slides and webcasts... and much more.
Become an ESMO member today!
18 Mar 2019
Trial of prophylactic cranial radiation achieved only a disease-free survival benefit in patients with stage III non-small-cell lung cancer
15 Mar 2019
The likelihood and timing of breast cancer relapse may be predicted by genomic analysis
14 Mar 2019
The MyPathway basket trial adds support for dual HER2-targeted therapy for HER2-amplified metastatic colorectal cancer
13 Mar 2019
A unique pattern of intracranial progression has been detected in patients who undergo neurosurgery and cavity radiation for brain metastases
12 Mar 2019
Non-small-cell lung cancer patients given PD-1 or PD-L1 inhibitors followed by osimertinib may have an elevated risk of toxicity
Reporting from ASCO GU, Bradley McGregor comments on Renal cell carcinoma studies results: JAVELIN, KEYNOTE-426, CheckMate 214, KEYNOTE-427 and a phase II study of atezolizumab and bevacizumab
06-08 Mar 2019, Manchester, United Kingdom
25-27 Feb 2019, Paris, France
22-22 Feb 2019, Valencia, Spain
15-17 Feb 2019, Cape Town, South Africa
01-02 Feb 2019, Lugano, Switzerland
13-16 Dec 2018, Geneva, Switzerland
02-03 Dec 2018, Milan, Italy
26-27 Nov 2018, Singapore
26-27 Nov 2018, Singapore
23-25 Nov 2018, Singapore, Singapore
23-24 Nov 2018, Zurich, Switzerland
21-22 Nov 2018, Singapore
20-22 Nov 2018, Singapore
20-21 Nov 2018, Singapore
16-17 Nov 2018, Lugano, Switzerland
